142 related articles for article (PubMed ID: 31212137)
1. Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant.
Vrieling H; Espitia Ballestas M; Hamzink M; Willems GJ; Soema P; Jiskoot W; Kersten G; Metz B
Colloids Surf B Biointerfaces; 2019 Sep; 181():648-656. PubMed ID: 31212137
[TBL] [Abstract][Full Text] [Related]
2. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
3. Antigenic fingerprinting of diphtheria toxoid adsorbed to aluminium phosphate.
Westdijk J; Metz B; Spruit N; Tilstra W; van der Gun J; Hendriksen C; Kersten G
Biologicals; 2017 May; 47():69-75. PubMed ID: 28259519
[TBL] [Abstract][Full Text] [Related]
4. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
al-Shakhshir R; Regnier F; White JL; Hem SL
Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
[TBL] [Abstract][Full Text] [Related]
5. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
[TBL] [Abstract][Full Text] [Related]
6. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
[TBL] [Abstract][Full Text] [Related]
7. Stability of aluminium-containing adjuvants to autoclaving.
Burrell LS; Lindblad EB; White JL; Hem SL
Vaccine; 1999 Jun; 17(20-21):2599-603. PubMed ID: 10418908
[TBL] [Abstract][Full Text] [Related]
8. Effect of different concentrations of diphtheria toxoid & aluminum phosphate on potency of diphtheria component in DPT vaccines.
Gupta P; Saxena SN; Kumar A; Gupta P
Indian J Med Res; 1990 May; 91():171-3. PubMed ID: 2118880
[TBL] [Abstract][Full Text] [Related]
9. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
10. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part II: physicochemical properties.
Burrell LS; Johnston CT; Schulze D; Klein J; White JL; Hem SL
Vaccine; 2000 Sep; 19(2-3):282-7. PubMed ID: 10930683
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy.
Bansal V; Kumar M; Dalela M; Brahmne HG; Singh H
Int J Pharm; 2014 Aug; 471(1-2):377-84. PubMed ID: 24939616
[TBL] [Abstract][Full Text] [Related]
12. Stability of aluminium-containing adjuvants during aging at room temperature.
Burrell LS; White JL; Hem SL
Vaccine; 2000 Apr; 18(21):2188-92. PubMed ID: 10717337
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials of diphtheria toxoid aluminium-phosphate-precipitated; to determine optional aluminium-phosphate content.
BOUSFIELD G
Lancet; 1947 Mar; 1(6443-6445):286-8. PubMed ID: 20287148
[No Abstract] [Full Text] [Related]
14. Shear effects on aluminum phosphate adjuvant particle properties in vaccine drug products.
Kolade OO; Jin W; Tengroth C; Green KD; Bracewell DG
J Pharm Sci; 2015 Feb; 104(2):378-87. PubMed ID: 25175154
[TBL] [Abstract][Full Text] [Related]
15. Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; Redwan EM
Hum Antibodies; 2017; 25(1-2):23-29. PubMed ID: 27858706
[TBL] [Abstract][Full Text] [Related]
16. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
Aggerbeck H; Heron I
Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
[TBL] [Abstract][Full Text] [Related]
17. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants.
al-Shakhshir RH; Regnier FE; White JL; Hem SL
Vaccine; 1995 Jan; 13(1):41-4. PubMed ID: 7762276
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of a diphtheria toxoid specific antibody response in human peripheral blood lymphocytes cultivated in the presence of diphtheria toxoid.
Loggen HG; Kreeftenberg JG
J Biol Stand; 1989 Oct; 17(4):311-9. PubMed ID: 2613706
[TBL] [Abstract][Full Text] [Related]
20. Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue.
Redhead K; Quinlan GJ; Das RG; Gutteridge JM
Pharmacol Toxicol; 1992 Apr; 70(4):278-80. PubMed ID: 1608913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
